{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:09:51Z","timestamp":1764432591921},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.drugpo.2007.04.002","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T11:08:39Z","timestamp":1182424119000},"page":"66-70","source":"Crossref","is-referenced-by-count":8,"title":["Integrating enhanced hepatitis C testing and counselling in research"],"prefix":"10.1016","volume":"19","author":[{"given":"Rebecca","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duyen","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"My Li","family":"Thach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Campbell","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09595230220119327","article-title":"Peer-delivered hepatitis C testing and counselling: A means of improving the health of injecting drug users","volume":"21","author":"Aitken","year":"2002","journal-title":"Drug and Alcohol Review"},{"issue":"9","key":"10.1016\/j.drugpo.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/424678","article-title":"Molecular epidemiology of hepatitis C virus in a social network of injection drug users","volume":"190","author":"Aitken","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/j.drugpo.2007.04.002_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2893.2005.00592.x","article-title":"Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users","volume":"12","author":"Bowden","year":"2005","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/sti.2004.009423","article-title":"Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling","volume":"81","author":"Bradshaw","year":"2005","journal-title":"Sexually Transmitted Infections"},{"issue":"11","key":"10.1016\/j.drugpo.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/jlts.2003.50244","article-title":"Scope of worldwide hepatitis C problem","volume":"9","author":"Brown","year":"2003","journal-title":"Liver Transplantation"},{"issue":"3","key":"10.1016\/j.drugpo.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(00)00154-X","article-title":"Dynamics of behavioural risk factors for HIV\/AIDS: A 6-year prospective study of injection drug users","volume":"61","author":"Celentano","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugpo.2004.12.002","article-title":"Clients or colleagues? Reflections on the process of participatory action research with young injecting drug users","volume":"16","author":"Coupland","year":"2005","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5694\/j.1326-5377.1997.tb138757.x","article-title":"Incidence of blood borne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990\u20131995","volume":"167","author":"Crofts","year":"1997","journal-title":"The Medical Journal of Australia"},{"issue":"6","key":"10.1016\/j.drugpo.2007.04.002_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF01719282","article-title":"Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV","volume":"10","author":"Crofts","year":"1994","journal-title":"European Journal of Epidemiology"},{"issue":"8","key":"10.1016\/j.drugpo.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1360-0443.1996.918118710.x","article-title":"The first hit: Circumstances surrounding initiation into injecting","volume":"91","author":"Crofts","year":"1996","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1369-6513.2002.00158.x","article-title":"Harnessing expertise: Involving peer interviewers in qualitative research with hard-to-reach populations","volume":"5","author":"Elliott","year":"2002","journal-title":"Health Expectations"},{"issue":"9","key":"10.1016\/j.drugpo.2007.04.002_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1360-0443.2001.969131911.x","article-title":"For love or money? An exploratory study of why injecting drug users participate in research","volume":"96","author":"Fry","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2007.04.002_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7556\/jaoa.1994.94.10.825","article-title":"HIV prevention: Factors that predict compliance with testing and counselling procedures","volume":"94","author":"Fry","year":"1994","journal-title":"Journal of the American Osteopathic Association"},{"key":"10.1016\/j.drugpo.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1360-0443.1993.tb02036.x","article-title":"Reaching hidden populations of drug users by privileged access interviewers: Methodological and practical issues","volume":"88","author":"Griffiths","year":"1993","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib15","first-page":"24","article-title":"Doing peer-based research with ethnic Vietnamese heroin users","volume":"3","author":"Higgs","year":"2005","journal-title":"New Community Quarterly"},{"issue":"5","key":"10.1016\/j.drugpo.2007.04.002_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/09595230600876606","article-title":"Engagement, reciprocity and advocacy: Ethical harm reduction practice in research with injecting drug users","volume":"25","author":"Higgs","year":"2006","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09687630110087392","article-title":"Involving Big Issue vendors in a peer education initiative to reduce drug-related harm: A feasibility study","volume":"9","author":"Hunter","year":"2002","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1527154403258312","article-title":"Lessons learned about barriers to hepatitis C testing: Implications for policy","volume":"4","author":"Instone","year":"2003","journal-title":"Policy, Politics, & Nursing Practice"},{"issue":"2","key":"10.1016\/j.drugpo.2007.04.002_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0749-3797(01)00324-5","article-title":"Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people","volume":"21","author":"Kalichman","year":"2001","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.drugpo.2007.04.002_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.280.13.1161","article-title":"Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT Study Group","volume":"280","author":"Kamb","year":"1998","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4065\/79.1.51","article-title":"Prevalence of human immunodeficiency virus testing in patients with hepatitis B and C infection","volume":"79","author":"Krain","year":"2004","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"10.1016\/j.drugpo.2007.04.002_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1360-0443.1997.tb03202.x","article-title":"The Swiss Hidden Population Study: Practical and methodological aspects of data collection by privileged access interviewers","volume":"92","author":"Kuebler","year":"1997","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugpo.2007.04.002_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1467-842X.1998.tb01418.x","article-title":"Vietnamese-speaking injecting drug users in Melbourne: The need for harm reduction programs","volume":"22","author":"Louie","year":"1998","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1467-842X.2001.tb00550.x","article-title":"Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne","volume":"25","author":"Maher","year":"2001","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"6","key":"10.1016\/j.drugpo.2007.04.002_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/1047-2797(94)90007-8","article-title":"Human immunodeficiency virus type 1 antibody status and changes in risk behaviour among drug users","volume":"4","author":"McCusker","year":"1994","journal-title":"Annals of Epidemiology"},{"issue":"4 Suppl. 3","key":"10.1016\/j.drugpo.2007.04.002_bib26","first-page":"iii59","article-title":"HIV prevention among injection drug users: The need for integrated models","volume":"80","author":"Metzger","year":"2003","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.drugpo.2007.04.002_bib27","first-page":"1","article-title":"Predictors of failure to return for HIV test result and counselling by test site type","volume":"11","author":"Molitor","year":"1999","journal-title":"AIDS Education and Prevention"},{"issue":"4","key":"10.1016\/j.drugpo.2007.04.002_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1521\/aeap.15.5.309.23821","article-title":"HIV testing and counselling: Test providers\u2019 experiences of best practices","volume":"15","author":"Myers","year":"2003","journal-title":"AIDS Education & Prevention"},{"key":"10.1016\/j.drugpo.2007.04.002_bib29","unstructured":"National Centre in HIV Epidemiology and Clinical Research (NCHECR). Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006. Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, Hepatitis C Subcommittee. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, October 2006."},{"issue":"4","key":"10.1016\/j.drugpo.2007.04.002_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/09687630110028280","article-title":"Ethnic communities\u2019 vulnerability to involvement with illicit drugs","volume":"8","author":"Reid","year":"2001","journal-title":"Drugs: Education, Prevention & Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2007.04.002_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0955-3959(02)00012-9","article-title":"Vulnerability among Vietnamese illicit drug users in Australia: Challenges for change","volume":"13","author":"Reid","year":"2002","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1258\/0956462054094105","article-title":"Mobile post-HIV test counselling","volume":"16","author":"Reynolds","year":"2005","journal-title":"International Journal of STD & AIDS"},{"key":"10.1016\/j.drugpo.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200405210-00011","article-title":"Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multiclinic assessment","volume":"18","author":"Richardson","year":"2004","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.drugpo.2007.04.002_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1746.2003.03270.x","article-title":"Surveillance for newly acquired hepatitis C in Australia","volume":"19","author":"Robotin","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"9","key":"10.1016\/j.drugpo.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2007.04.002_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1521\/aeap.13.6.524.21436","article-title":"Moving from apprehension to action: HIV counselling and testing preferences in three at-risk populations","volume":"13","author":"Spielberg","year":"2001","journal-title":"AIDS Education and Prevention"},{"key":"10.1016\/j.drugpo.2007.04.002_bib37","doi-asserted-by":"crossref","unstructured":"Treloar, C. J., Hopwood M. N., & Loveday S. K. (2002). Hepatitis C-related discrimination in healthcare. Report of the Third Australasian Conference on Hepatitis C, Melbourne, March 202. The Medical Journal of Australia, 177(5), 233\u2013234.","DOI":"10.5694\/j.1326-5377.2002.tb04753.x"},{"issue":"11","key":"10.1016\/j.drugpo.2007.04.002_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/108729102761041092","article-title":"Desired elements of HIV testing services: Test recipient perspectives","volume":"16","author":"Worthington","year":"2002","journal-title":"AIDS Patient Care STDS"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395907000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395907000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T06:19:46Z","timestamp":1587622786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395907000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0955395907000898"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2007.04.002","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}